Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OnabotulinumtoxinA vs IncobotulinumtoxinA for Facial Wrinkles
NCT02122536Completed
- Sponsor
- YMD Eye and Face
- Start
- Jul 2012
- Primary completion
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in rhytides (2 arms), sponsored by YMD Eye and Face. Primary endpoint: Change in Wrinkles Score at 4 months. Started Jul 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
rhytides
Beyond the preview
Go deeper on NCT02122536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02122536.